PainReform

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PainReform and other ETFs, options, and stocks.

About PRFX

PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. 

CEO
Ehud Geller
CEOEhud Geller
Employees
6
Employees6
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2007
Founded2007
Employees
6
Employees6

PRFX Key Statistics

Market cap
3.37M
Market cap3.37M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
90.83K
Average volume90.83K
High today
$0.92
High today$0.92
Low today
$0.8079
Low today$0.8079
Open price
$0.8775
Open price$0.8775
Volume
68.70K
Volume68.70K
52 Week high
$6.65
52 Week high$6.65
52 Week low
$0.801
52 Week low$0.801

Stock Snapshot

With a market cap of 3.37M, PainReform(PRFX) trades at $0.86.

As of 2025-12-24, PainReform(PRFX) stock has fluctuated between $0.81 and $0.92. The current price stands at $0.86, placing the stock +6.1% above today's low and -6.8% off the high.

PainReform(PRFX) shares are trading with a volume of 68.7K, against a daily average of 90.83K.

In the last year, PainReform(PRFX) shares hit a 52-week high of $6.65 and a 52-week low of $0.80.

In the last year, PainReform(PRFX) shares hit a 52-week high of $6.65 and a 52-week low of $0.80.

People also own

Based on the portfolios of people who own PRFX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.